WHO position on the use of fractional doses - June 2017, addendum to vaccines and vaccination against yellow fever WHO: Position paper - June 2013.
World Health Organization.
; 35(43): 5751-5752, 2017 10 13.
Artigo em Inglês | MEDLINE | ID: mdl-28689653
Yellow fever vaccine for patients with HIV infection.
Single shot of 17D vaccine may not confer life-long protection against yellow fever.
Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Final Report.
Long-Term Protection After Fractional-Dose Yellow Fever Vaccination: Follow-up Study of a Randomized, Controlled, Noninferiority Trial.
New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.
Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.
[Anti-NMDAR encephalitis as a serious adverse event probably related to yellow fever vaccination].
Sanger-based sequencing technology for yellow fever vaccine genetic quality control.
Rules to 'prime' by.
Immunogenicity and Safety of Yellow Fever Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients After Withdrawal of Immunosuppressive Therapy.